IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. - Wikidata - wikimedia - TriplyDB

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

http://www.wikidata.org/entity/Q33405619

about

Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children A simple method to quantitate IP-10 in dried blood and plasma spots Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients.Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.The immunology of tuberculosis: from bench to bedside.Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.Discriminating between latent and active tuberculosis with multiple biomarker responses.Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-γ responses.IP-10 Is a Sensitive Biomarker of Antigen Recognition in Whole-Blood Stimulation Assays Used for the Diagnosis of Mycobacterium bovis Infection in African Buffaloes (Syncerus caffer).Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle.Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.Tuberculosis diagnostics: Challenges and opportunities Development and evaluation of a diagnostic cytokine-release assay for Mycobacterium suricattae infection in meerkats (Suricata suricatta).Emerging trends in the diagnosis of human African Trypanosomiasis.Biomarkers of latent TB infection.Immunological biomarkers of tuberculosis.Redefining latent tuberculosis.Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Tuberculosis diagnostics for children in high-burden countries: what is available and what is needed.Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations.MIGRAs: are they the new IGRAs? Development of monokine-amplified IFN-γ release assays.Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.

P2860

Q26852073-F2CB8414-39EC-489F-B9F9-25B1E5A75A78 Q28727912-FE0249E0-D603-4D2A-80A5-69CC2063119B Q28729980-AC4F8AE1-F2BE-4F9F-8B67-490672FF4250 Q28742421-5537EACF-FBB6-4D33-939C-A8F2892E3D12 Q30390343-2252766E-5058-4373-B1EF-6600C4E338EE Q33627062-3CFA5FD1-3E8A-43F1-8268-0E9DD518674F Q33777367-08B95E4B-9B92-44B0-8F1C-8B3E9D47CACA Q33825672-627618ED-C790-4A32-A999-07325687353D Q33905874-EF54A1F5-3BBD-4CFE-A675-260B1FC3CFAA Q34037749-CC07D9B2-06EC-496B-A96E-1D2D6EB3B4CC Q34478705-AE9AF066-4D59-40B8-86A9-DBE98A50FCD5 Q34593096-781CF16D-6753-4195-88D0-612D16F35386 Q34612744-65E03FA5-8B4D-4786-ACD1-FC687A01FA06 Q34790516-75E23918-AA68-4791-980B-4047606EFA93 Q34958633-47402551-872D-4482-B0FF-B167C1F32639 Q34983098-E693AA88-BE60-469E-8BF4-0063DE5BECA5 Q35048697-968CB06D-0807-42DF-9334-99EB1B8BFAF4 Q35138642-C38054AA-3918-4EF6-8AF4-28C63B741A60 Q35361654-64239D04-AC84-4262-BB3F-A7F3C2F0B6BB Q35469531-40561C69-C735-4F6A-8C16-BD7717A1F7D3 Q35805257-5A47B7E7-EB1B-4F94-B1EF-176AF62DA40C Q35902024-FE45D6E2-34DD-4F9B-9BBF-3F5476D09803 Q35906959-05D35C76-85B6-4714-8DD1-102E8F394A0E Q35936136-6306D042-E3B4-4BEB-88DB-ACEC8640ADAE Q35976624-46F76752-CED7-47DD-B1DE-8F954F388B7C Q36014226-C596DDA9-F663-4C97-A847-0298CA647557 Q36148431-571A1D14-5A5A-48BC-B5CE-E0926866696C Q36181008-6272F30E-7973-4FE4-A061-18A0ADFA793D Q36239765-E16AFEC3-3190-4EA4-8032-F4542458CB51 Q37728108-34ECD416-2CF4-4AD2-AD29-24D17EE1AE2E Q37755029-23B06DF4-AEC3-4F7B-9F5B-33DB1BB7B84A Q37862987-218BC570-6209-47E4-99DC-8B666A31501D Q37940571-B81FE1A7-4EFE-40BE-9630-011627D23126 Q37953955-33BA4BDD-E2A6-4B4F-B346-EE31DE09EC1A Q37988577-0DD8C8A2-8C69-4A0D-87E8-1F6A1D717004 Q38080198-9C4C4E09-8F74-44B8-9718-85642F16609E Q38258595-6D5CA0B0-AF79-4CCD-AF25-5A15143BB2E2 Q39636573-CEB62B62-6CD4-43C2-B617-9D386A1EAB57 Q42067111-075597BC-15D9-4D5C-A015-5FC2D1F79F82 Q47833651-7A61A9F1-DC55-4E4F-9871-29289B69F80A

P2860

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

http://www.wikidata.org/entity/Q33405619

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@ast

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@en

type

label

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@ast

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@en

prefLabel

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@ast

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@en

P1433

Q33405619-E282F6B5-DD2E-489C-AE69-B5C46F12A4D2

P1476

Q33405619-A66DB926-02E9-4284-BD61-C8B511B7A168

P2093

Q33405619-88BE9B76-E2CC-41B2-BE42-1B51C0B0ECB0

Q33405619-9CD9B076-057F-443C-80CE-EAEF4B267EBE

Q33405619-AAEF3E36-F1AC-46C8-98ED-CCC7386A6BC4

Q33405619-C0C6E06D-5A9B-4C3E-A6EA-937470F91110

P2860

Q33405619-297A7B78-CB3B-49D5-873D-B3802DFB5F0E

Q33405619-4191C715-7D81-45B0-8709-4C082F38DDFB

Q33405619-4593C9BA-DC04-4FAC-8EA7-918FB1A70FA6

Q33405619-4CB30274-B89B-417D-B0E0-8EF66810093B

Q33405619-56060029-2AA5-4AE0-B8E9-8B06411F81E6

Q33405619-637D65C4-6297-4E1F-99E8-6EF443BB0F19

Q33405619-7B2894DF-CF0B-4C8F-9B7D-665EDD031181

Q33405619-7F143167-7CAB-40F1-AD37-05025169BB3D

Q33405619-7FEDEE60-EBC8-4D1F-8341-6ABA8A56DEA3

Q33405619-889CD141-C904-4258-99EF-7792E24CA156

P2888

Q33405619-6D4C07FA-419C-4A12-B374-B8B243B9DE9E

P304

Q33405619-267287EB-DAFD-47A2-9877-7554E9A0D370

P31

Q33405619-14EA2E26-2A71-4FC1-9EEC-CFD6F65DB612

P356

Q33405619-4D28F9B2-E915-4EDA-9FD1-FA6AE39A6BFB

P478

Q33405619-844F032D-9921-4EBA-AB84-42E381C2BDD9

P50

Q33405619-10F27342-C555-46D0-AA2D-76D2D6C59AD8

Q33405619-458FC661-A594-43E0-922E-EED57E6DCBE1

P577

Q33405619-841F02D0-006F-4EC0-BCEB-22EAD3A81EEF

P5875

Q33405619-E88D9AFD-8165-477F-9F8C-1E7DAF8FABFF

P6179

Q33405619-DB42B803-4A60-41E5-A305-40994050CDDD

P698

Q33405619-29466B35-91C7-4BD4-835E-4B6284B23F57

P921

Q33405619-09020894-6282-437B-BCE3-09569F49D838

Q33405619-0D371A07-71D5-41C1-9226-51B048F08515

Q33405619-F373BAB1-5B92-4B44-BBA9-84994CE40C9A

P932

Q33405619-1744BBC9-14A1-478E-BAA6-59508E5050E2

P356

P1433

BMC Research Notes

P1476

IP-10, MCP-1, MCP-2, MCP-3, an ...... hole blood based T-cell assay.

@en

P2093

Morten Bjerregaard-Andersen

http://www.w3.org/2001/XMLSchema#string

Morten Ruhwald

http://www.w3.org/2001/XMLSchema#string

Paulo Rabna

http://www.w3.org/2001/XMLSchema#string

Pernille Ravn

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach

Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.

Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection.

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test.

P2888

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-2-19

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Morten Bjerregaard-Andersen

Jesper Eugen-Olsen

P577

2009-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23979726

http://www.w3.org/2001/XMLSchema#string

P6179

1044074331

http://www.w3.org/2001/XMLSchema#string

P698

19193208

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

Mycobacterium tuberculosis

P932

2660909

http://www.w3.org/2001/XMLSchema#string